Willmore, E. Et Al. 2017. Activation of p53 by the MDM2 Antagonist RG7388 in CLL Cells:Analysis of ExVivo Signalling, Cell Death and Gene Signature. The biennial International Workshop on Chronic Lymphocytic Leukemia , (New York, United States Of America).

Willmore, E., Ciardullo, C., APTULLAHOĞLU, E., Woodhouse, L., Wallis, J. P., Marr, H., ... Lunec, J.(2017). Activation of p53 by the MDM2 Antagonist RG7388 in CLL Cells:Analysis of ExVivo Signalling, Cell Death and Gene Signature . The biennial International Workshop on Chronic Lymphocytic Leukemia, New York, United States Of America

Willmore, Elaine Et Al. "Activation of p53 by the MDM2 Antagonist RG7388 in CLL Cells:Analysis of ExVivo Signalling, Cell Death and Gene Signature," The biennial International Workshop on Chronic Lymphocytic Leukemia, New York, United States Of America, 2017

Willmore, Elaine Et Al. "Activation of p53 by the MDM2 Antagonist RG7388 in CLL Cells:Analysis of ExVivo Signalling, Cell Death and Gene Signature." The biennial International Workshop on Chronic Lymphocytic Leukemia , New York, United States Of America, 2017

Willmore, E. Et Al. (2017) . "Activation of p53 by the MDM2 Antagonist RG7388 in CLL Cells:Analysis of ExVivo Signalling, Cell Death and Gene Signature." The biennial International Workshop on Chronic Lymphocytic Leukemia , New York, United States Of America.

@conferencepaper{conferencepaper, author={Elaine Willmore Et Al. }, title={Activation of p53 by the MDM2 Antagonist RG7388 in CLL Cells:Analysis of ExVivo Signalling, Cell Death and Gene Signature}, congress name={The biennial International Workshop on Chronic Lymphocytic Leukemia}, city={New York}, country={United States Of America}, year={2017}}